Previous 10 | Next 10 |
The Company has Now Resumed the Clinical Development of its Proposed Anti-Nausea Pharmaceutical Grade Version of Tauri-Gum™ NEW YORK, NY, Dec. 24, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the ȁ...
This Product Line Expansion Will Include 2 Distinct Cannabigerol (“CBG”) Infused Bath Bomb Fragrances NEW YORK, NY, Dec. 23, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”...
The Company Plans to Launch its Tauri-Gum™ Product Line throughout Mainland China, During Calendar Year 2021 NEW YORK, NY, Dec. 21, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company...
The Company’s Proposed Pharma Grade Version of Tauri-Gum™ is Being Developed Specifically to Target: Patients Subjected to Ongoing Chemotherapy Treatment (the “Indication”) NEW YORK, NY, Dec. 18, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Taur...
Tauriga Sciences (TAUG) announces the resumption of clinical development for its proposed “Anti-Nausea” pharmaceutical-grade version of Tauri-Gum™. The company, focused on the Cannabidiol and Cannabigerol Edibles market, filed a provisional U.S. patent in M...
Snapshot of U.S. Patent Assignment / PTAS (# 506080043)
NEW YORK, NY, Dec. 16, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement...
The “Swipe Up” Feature has been Activated, Enhancing the Company’s E-Commerce Business NEW YORK, NY, Dec. 14, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a...
NEW YORK, NY - ( NewMediaWire ) - December 11, 2020 - Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Fla...
This Product is Comprised of Raw Linden Honey Infused with 500mg CBD / Each Jar Contains 20 Servings (25mg CBD per Serving) NEW YORK, NY, Dec. 08, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Com...
News, Short Squeeze, Breakout and More Instantly...
Tauriga Sciences Inc (TAUG) is expected to report for Q3 2023
NEW YORK, NY - ( NewMediaWire ) - May 13, 2022 - Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York-based diversified Life Sciences and Pharmaceutical Development Company, today announced that the online shopping research platform, FindT...
New York, NY, May 09, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences and Pharmaceutical Development Company, today announced that its Chief Ex...